Mirion Technologies, Inc.

Valuation Analysis

About the Company

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. T

Mirion Technologies, Inc. Stock at a Glance

Mirion Technologies, Inc. (MIR) is currently trading at $16.56 with a market capitalization of $4.1B. The trailing P/E ratio stands at 165.6x, with a forward P/E of 25.33x. The 52-week range spans from $15.58 to $30.28; the current price is 45.3% below the yearly high. Year-over-year revenue growth stands at +27.5%. The net profit margin stands at 2.56%.

💰 Dividend

Mirion Technologies, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

10 analysts rate Mirion Technologies, Inc. (MIR) on consensus: None. The average price target is $27.90, implying +68.48% from the current price. Analyst price targets range from $26.00 to $29.00.

Mirion Technologies, Inc.: The Investment Case in Detail

Mirion Technologies, Inc. (MIR) operates in the Industrials — specifically Specialty Industrial Machinery — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Top-line momentum is unusually strong with revenue expanding 27.5% year-over-year, a pace that puts the company well above the market average and signals genuine demand traction rather than mere cyclical tailwind.

The Bear Case

With a net margin of just 2.56%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. Short interest sits at 18.8% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

What to Watch Next

• The forward P/E of 25.33x is meaningfully below the trailing 165.6x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 68.48% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Risk Profile

The data points to market-like volatility, elevated short interest (18.8%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Mirion Technologies, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.